Nanobiotix: Nanobiotix S.A. Reports Earnings Results for the Full Year Ended December 31, 2024

Nanobiotix S.A. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported negative sales was EUR 11.61 million compared to sales of EUR 30.06 million a year ago. Negative revenue was EUR 7.19 million compared to revenue of EUR 36.21 million a year ago. Net loss was EUR 68.13 million compared to EUR 39.7 million a year ago. Basic loss per share from continuing operations was EUR 1.44 compared to EUR 1.08 a year ago. Diluted loss per share from continuing operations was EUR 1.44 compared to EUR 1.08 a year ago. Nanobiotix S.A. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported negative sales was EUR 11.61 million compared to sales of EUR 30.06 million a year ago. Negative revenue was EUR 7.19 million compared to revenue of EUR 36.21 million a year ago. Net loss was EUR 68.13 million compared to EUR 39.7 million a year ago. Basic loss per share from continuing operations was EUR 1.44 compared to EUR 1.08 a year ago. Diluted loss per share from continuing operations was EUR 1.44 compared to EUR 1.08 a year ago.